Literature DB >> 18565609

Declining prevalence of diabetes mellitus in hereditary haemochromatosis--the result of earlier diagnosis.

E P O'Sullivan1, J H McDermott, M S Murphy, S Sen, C H Walsh.   

Abstract

AIMS: The aims of this study were to describe the prevalence and clinical features of diabetes in hereditary haemochromatosis (HH), with particular emphasis to how this has changed since the introduction of genetic testing in 1996. SUBJECTS AND METHODS: Two hundred and thirty-seven patients were diagnosed with HH (based on elevated iron indices and liver biopsy or genetic testing) by a single physician, and all biochemical and clinical data recorded from diagnosis to the end of the study.
RESULTS: The prevalence of diabetes (21.9%) was lower than most previously published studies. There was a significantly greater prevalence of diabetes and cirrhosis in those diagnosed before the introduction of genetic testing, p<0.001. The type of genetic mutation for HH, degree of ferritin elevation at diagnosis, or the presence of cirrhosis was not predictive for the development of diabetes. Iron depletion did not result in an improvement in glycaemic control or reduction in insulin requirements in the majority of patients.
CONCLUSIONS: This is one of the largest published series of diabetes in HH. Because the occurrence of diabetes in patients with HH reduces life expectancy, our finding of a lower prevalence of diabetes is expected to translate into a greater survival rate in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565609     DOI: 10.1016/j.diabres.2008.05.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 2.  Pleiotropic actions of iron balance in diabetes mellitus.

Authors:  Xinhui Wang; Xuexian Fang; Fudi Wang
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 3.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 4.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

5.  Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.

Authors:  James C Barton; J Clayborn Barton; Paul C Adams; Ronald T Acton
Journal:  Metab Syndr Relat Disord       Date:  2016-01-15       Impact factor: 1.894

6.  Total mortality by elevated transferrin saturation in patients with diabetes.

Authors:  Christina Ellervik; Henrik Ullits Andersen; Anne Tybjærg-Hansen; Merete Frandsen; Henrik Birgens; Børge G Nordestgaard; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2013-06-25       Impact factor: 19.112

Review 7.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.